Evidence map›Paper›PMID 30152571›Full record

ArticleWound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society2018

Deferoxamine can prevent pressure ulcers and accelerate healing in aged mice.

Clark A Bonham, Melanie Rodrigues, Michael Galvez, Artem Trotsyuk, Zachary Stern-Buchbinder, Mohammed Inayathullah, Jayakumar Rajadas, Geoffrey C Gurtner

Abstract read
In one paragraph

Article in Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Clark A BonhamDepartment of Surgery, Stanford University School of Medicine, Stanford, California.
Melanie RodriguesDepartment of Surgery, Stanford University School of Medicine, Stanford, California.
Michael GalvezDepartment of Surgery, Stanford University School of Medicine, Stanford, California.
Artem TrotsyukDepartment of Surgery, Stanford University School of Medicine, Stanford, California.
Zachary Stern-BuchbinderDepartment of Surgery, Stanford University School of Medicine, Stanford, California.
Mohammed InayathullahDepartment of Surgery, Stanford University School of Medicine, Stanford, California.ORCID 0000-0001-7646-1709
Jayakumar RajadasDepartment of Surgery, Stanford University School of Medicine, Stanford, California.
Geoffrey C GurtnerDepartment of Surgery, Stanford University School of Medicine, Stanford, California.
Stanford Medicine · US

Funding

Reversal of Progenitor Cell Deficits in DiabetesR01DK074095 · NIDDK · UNIVERSITY OF ARIZONA · PI GURTNER, GEOFFREY C · 2005 to 2025
$6.4M
Targeting HIF-1 alpha Dysfunction in Complications of AgingR01AG025016 · NIA · STANFORD UNIVERSITY · PI GURTNER, GEOFFREY C · 2004 to 2015
$3.5M
Progenitor Cell Dysfunction and Impaired Neovascularization in DiabetesR56DK074095 · NIDDK · STANFORD UNIVERSITY · PI BROWNLEE, MICHAEL A, GURTNER, GEOFFREY C · 2009 to 2009
$500k
NIA NIH HHS R01 AG025016NIDDK NIH HHS R01 DK074095NIDDK NIH HHS R56 DK074095
6 · The paper itself

Abstract

Chronic wounds are a significant medical and economic problem worldwide. Individuals over the age of 65 are particularly vulnerable to pressure ulcers and impaired wound healing. With this demographic growing rapidly, there is a need for effective treatments. We have previously demonstrated that defective hypoxia signaling through destabilization of the master hypoxia-inducible factor 1α (HIF-1α) underlies impairments in both aging and diabetic wound healing. To stabilize HIF-1α, we developed a transdermal delivery system of the Food and Drug Administration-approved small molecule deferoxamine (DFO) and found that transdermal DFO could both prevent and treat ulcers in diabetic mice. Here, we demonstrate that transdermal DFO can similarly prevent pressure ulcers and normalize aged wound healing. Enhanced wound healing by DFO is brought about by stabilization of HIF-1α and improvements in neovascularization. Transdermal DFO can be rapidly translated into the clinic and may represent a new approach to prevent and treat pressure ulcers in aged patients.

Indexed as

Administration, CutaneousAnimalsDeferoxamineDisease Models, AnimalMiceMice, Inbred C57BLNeovascularization, PhysiologicPressure UlcerSiderophoresWound HealingDeferoxamineSiderophores

Identifiers

PMID30152571
PMCPMC6238634
OpenAlexW2889237718

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.